RT Journal Article
SR Electronic
T1 Barrier gesture relaxation during vaccination campaign in France: modelling impact of waning immunity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.29.21262788
DO 10.1101/2021.08.29.21262788
A1 Carole Vignals
A1 David W. Dick
A1 Rodolphe Thiébaut
A1 Linda Wittkop
A1 Mélanie Prague
A1 Jane Heffernan
YR 2021
UL http://medrxiv.org/content/early/2021/08/30/2021.08.29.21262788.abstract
AB Non-pharmaceutical interventions have been implemented intermittently for more than a year in most countries of the world to mitigate COVID-19 epidemic. In France, while the vaccination campaign is progressing, the French government has decided to remove many public health restrictions such as business closure, lockdowns and curfews. Nonetheless, social distancing, mask wearing, and hand washing (also called barrier gestures) are still recommended. We utilize an age-structured compartmental SEIR model that takes into account SARS-CoV-2 waning immunity, vaccination, and increased transmissibility from variants of concern, to estimate if barrier gestures can be relaxed without causing a resurgence of severe infections. This model assumes that susceptibility to infection is a function of immunity status, which depends on initial infection severity and vaccination status. It is calibrated on confirmed COVID-19 cases from the French surveillance database, and accounts for changes in contact behaviors due to implementation of nation-wide public health policies. We study partial and full relaxation of barrier gestures occurring from August to December 2021 under various immunity duration assumptions. Maintaining application of barrier gestures appears essential to avoid a resurgence of severe infections that would exceed health care capacities, while surmounting vaccine hesitancy represents the key to consider their relaxation. Immunity duration assumptions significantly influence the short-term dynamic of the epidemic which should be considered for further modelling.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe thank Lauren Childs, Jing Li, Zhilan Feng, John Glasser and Gergely Rost for their discussions and input on this project. This research received no external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:A formal ethics approval was not needed for our modelling study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesVariants of concern data, reported COVID-19 cases data and prevalent intensive care units hospitalization data for France are publicly available online. https://www.data.gouv.fr/fr/datasets/donnees-de-laboratoires-pour-le-depistage-indicateurs-sur-les-variants/ https://www.data.gouv.fr/fr/datasets/donnees-relatives-aux-resultats-des-tests-virologiques-covid-19/ https://geodes.santepubliquefrance.fr/#c=indicator&f=0&i=covid_hospit.rea&s=2021-08-03&t=a01&view=map2